These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 26852015)
1. Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer. Cao WM; Gao Y; Yang HJ; Xie SN; Ding XW; Pan ZW; Ye WW; Wang XJ BMC Cancer; 2016 Feb; 16():64. PubMed ID: 26852015 [TBL] [Abstract][Full Text] [Related]
2. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. Kwong A; Ng EK; Wong CL; Law FB; Au T; Wong HN; Kurian AW; West DW; Ford JM; Ma ES PLoS One; 2012; 7(9):e43994. PubMed ID: 22970155 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients. Kim YC; Zhao L; Zhang H; Huang Y; Cui J; Xiao F; Downs B; Wang SM Oncotarget; 2016 Feb; 7(8):9600-12. PubMed ID: 26848529 [TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families. Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231 [TBL] [Abstract][Full Text] [Related]
6. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients. Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Zhang J; Pei R; Pang Z; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y Breast Cancer Res Treat; 2012 Apr; 132(2):421-8. PubMed ID: 21614564 [TBL] [Abstract][Full Text] [Related]
8. Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families. Valarmathi MT; Sawhney M; Deo SSV; Shukla NK; Das SN Hum Mutat; 2004 Feb; 23(2):205. PubMed ID: 14722926 [TBL] [Abstract][Full Text] [Related]
9. Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer. Machackova E; Foretova L; Lukesova M; Vasickova P; Navratilova M; Coene I; Pavlu H; Kosinova V; Kuklova J; Claes K BMC Cancer; 2008 May; 8():140. PubMed ID: 18489799 [TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer. Shi T; Wang P; Xie C; Yin S; Shi D; Wei C; Tang W; Jiang R; Cheng X; Wei Q; Wang Q; Zang R Int J Cancer; 2017 May; 140(9):2051-2059. PubMed ID: 28176296 [TBL] [Abstract][Full Text] [Related]
11. Genetic testing in Poland and Ukraine: should comprehensive germline testing of Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Steen JA; Theys D; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Stembalska A; Pesz K; Kitsera N; Siekierzynska A; Southey MC; Myszka A Genet Res (Camb); 2020 Aug; 102():e6. PubMed ID: 32772980 [TBL] [Abstract][Full Text] [Related]
12. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067 [TBL] [Abstract][Full Text] [Related]
13. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age. Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Rashid MU; Zaidi A; Torres D; Sultan F; Benner A; Naqvi B; Shakoori AR; Seidel-Renkert A; Farooq H; Narod S; Amin A; Hamann U Int J Cancer; 2006 Dec; 119(12):2832-9. PubMed ID: 16998791 [TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 mutations in a sample of breast and ovarian cancer families from the Colombian pacific. Cifuentes-C L; Rivera-Herrera AL; Barreto G Colomb Med (Cali); 2019 Sep; 50(3):163-175. PubMed ID: 32284662 [TBL] [Abstract][Full Text] [Related]
16. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls. Li A; Xie R; Zhi Q; Deng Y; Wu Y; Li W; Yang L; Jiao Z; Luo J; Zi Y; Sun G; Zhang J; Shi Y; Liu J Gynecol Oncol; 2018 Oct; 151(1):145-152. PubMed ID: 30078507 [TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers. Gabaldó Barrios X; Sarabia Meseguer MD; Marín Vera M; Sánchez Bermúdez AI; Macías Cerrolaza JA; Sánchez Henarejos P; Zafra Poves M; García Hernández MR; Cuevas Tortosa E; Aliaga Baño Á; Castillo Guardiola V; Martínez Hernández P; Tovar Zapata I; Martínez Barba E; Ayala de la Peña F; Alonso Romero JL; Noguera Velasco JA; Ruiz Espejo F Fam Cancer; 2017 Oct; 16(4):477-489. PubMed ID: 28477318 [TBL] [Abstract][Full Text] [Related]
18. Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients. Zhang Y; Wu H; Yu Z; Li L; Zhang J; Liang X; Huang Q BMC Cancer; 2022 Aug; 22(1):842. PubMed ID: 35918668 [TBL] [Abstract][Full Text] [Related]
19. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland. van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213 [TBL] [Abstract][Full Text] [Related]
20. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]